Roivant Sciences Ltd (ROIV)

Payables turnover

Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Cost of revenue (ttm) US$ in thousands 6,494 10,701 14,110 15,324 15,560 20,534 25,190 25,565 23,077 14,150 7,210 9,950 8,966 8,985 8,285 2,619 2,057 1,579
Payables US$ in thousands 23,691 23,712 25,127 53,225 35,226 35,226 44,123 50,035 37,830 47,999 41,358 161,304 34,583 24,358 77,158 15,014 20,550 —
Payables turnover 0.27 0.45 0.56 0.29 0.44 0.58 0.57 0.51 0.61 0.29 0.17 0.06 0.26 0.37 0.11 0.17 0.10 —

March 31, 2025 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $6,494K ÷ $23,691K
= 0.27

The payables turnover ratio of Roivant Sciences Ltd has shown fluctuations over the period from December 31, 2020, to March 31, 2025.

The payables turnover ratio started at an indeterminate value on December 31, 2020, and gradually increased to 0.61 on March 31, 2023, indicating that the company was able to pay off its accounts payable relatively quicker during that period.

However, the ratio decreased to 0.27 on March 31, 2025, suggesting that the company took longer to pay off its payables compared to the previous period.

Overall, the payables turnover ratio of Roivant Sciences Ltd has shown variability, with periods of both improvement and decline in the efficiency of paying off its accounts payable obligations. Further analysis is needed to understand the factors driving these changes and their implications for the company's working capital management.